Papers on liver fibrosis
464 papers29 new in 30 days
Thursday, July 30
Wednesday, July 29
Advanced Pharmaceutical Bulletin
Dual Modulation of Senescence and Immune Checkpoints by Metformin and Dapagliflozin Attenuates Liver Fibrosis in a Thioacetamide-Induced Rat Model
Experiments in ratsDapagliflozin
Frontiers in Immunology
Upregulated FASN-mediated lipogenesis in senescent macrophages contributes to liver fibrosis progression
Experiments in miceCellular senescence
Tuesday, July 28
Thursday, July 23
Tuesday, July 14
Journal of Obesity & Metabolic Syndrome
Metabolic Dysfunction-Associated Steatotic Liver Disease and Low Handgrip Strength Are Associated with a Higher Risk of Cardiovascular Disease
Cross-sectional study of 20,611 peopleMetabolic dysfunction-associated steatotic liver disease
Sunday, June 21
Yakut Medical Journal
Predictors of HBV-associated hepatocarcinoma: a scientific review
ReviewMechanisms
Saturday, June 6
ADA Scientific Sessions 2026 Abstract
Waist-to-Height Ratio Outperforms BMI in Identifying Hepatic Steatosis and Fibrosis in U.S. Adults
Cross-sectional study of 3,905 peopleHepatic steatosis
Friday, June 5
Hepatology Research
Serum Mac-2 Binding Protein Glycan Isomer and Cerebral White Matter Injury in Older Adults: A Hepatic-Cerebral Link
Cross-sectional study of 602 peopleBiomarkers
ADA Scientific Sessions 2026 Abstract
Longitudinal Dynamics of Cardiometabolic Parameters in a MASH Population Stratified by Baseline Glycemia and Treated with Semaglutide: Post Hoc Insights from the ESSENCE Trial Part 1
Randomized trial in 800 peopleSemaglutide
ADA Scientific Sessions 2026 Abstract
Fibrosis-4 Index Is Associated with ASCVD Burden, MACE, and Mortality in Real-World Type 2 Diabetes Cohort
Cohort study of 8,900 peopleFibrosis-4 Index
Monday, June 1
Sunday, May 24
Wednesday, May 13
Hepatobiliary & Pancreatic Diseases International
Modulating hepatic stellate cell senescence: A promising therapeutic strategy for liver fibrosis
ReviewCellular senescence
Monday, April 20
Thursday, April 9
Saturday, March 28
Friday, March 27
Wednesday, March 25
Frontiers in Nutrition
Sarcopenia as a risk factor for nonalcoholic fatty liver disease and liver fibrosis: an updated systematic review and meta-analysis
Meta-analysis of observational studiesLiver fibrosis
Tuesday, March 24
bioRxiv
Time-restricted feeding exacerbates liver fibrosis by promoting BDH1-mediated ketolysis in hepatic stellate cells
Preprint: experiments in miceDietary restriction
Monday, March 23
European Journal of Gastroenterology & Hepatology
Comprehensive management of modifiable factors and all-cause mortality in patients with metabolic dysfunction-associated steatotic liver disease
Cohort study of 15,802 peopleMetabolic dysfunction-associated steatotic liver disease
Sunday, March 22
Biology of Reproduction
Reduced fertility induced by MASLD in female mice is improved by senolytic treatment†
Experiments in miceSenolytics
Friday, March 20
Advanced Materials
Ultrasound-Responsive Dual-Prodrug Nanoassembly for "Fenestrae-Restoration Strategy" in Liver Fibrosis Therapy
Experiments in miceUltrasound
Thursday, March 19
Advances in Laboratory Medicine
Comparison of diagnostic performance of GAAD, GALAD, and ASAP scores for detecting hepatocellular carcinoma in advanced liver fibrosis patients
Cohort study of 30 peopleHepatocellular carcinoma
The Journal of Steroid Biochemistry and Molecular Biology
Sexual dimorphism in liver fibrotic metabolic dysfunction: Effects of testosterone and estrogen on CCl₄-induced liver injury in ovariectomy and orchiectomy models
Experiments in miceTestosterone
Wednesday, March 18
JAMA Network Open
Liver Stiffness Measurement and All-Cause Mortality in Individuals With Diabetes
Cohort study of 4,102 peopleLiver stiffness measurement
Tuesday, March 17
Journal of Extracellular Vesicles
Circulating Liver-Derived and CD36⁺ Extracellular Vesicles Correlate With Ectopic Liver Fat and Markers of Fibrosis in Metabolic Dysfunction-Associated Steatotic Liver Disease and Decrease During Weight Loss Intervention
Non-randomized trial in peopleLiver fat content
Saturday, March 14
Research Square
SGLT2 inhibition attenuates γδ T cell–mediated meta-inflammation associated with cardiometabolic risk in type 2 diabetes
Preprint: cohort study of 30 peopleSGLT2 inhibitors
Wednesday, March 11
Tuesday, March 10
Annals of Hepatology
Optimal screening criteria for metabolic dysfunction-associated steatotic liver disease with fibrosis
Cross-sectional study of 75,124 peopleLiver fibrosis